Target intelligence / Profile preview

Nematode muscle nicotinic acetylcholine receptor (nAChR)

Target
nAChR
Molecular classification
Ion channel, Ligand-gated ion channel, Receptor, Cys-loop receptor family
01

Overview

The nematode muscle nicotinic acetylcholine receptor (nAChR) is a pentameric ligand-gated ion channel essential for excitatory neurotransmission at the nematode neuromuscular junction (Martin et al., 2012, PubMed). It is a primary target for anthelmintic drugs, which often exploit the receptor's open channel state to induce paralysis in parasitic worms. Agonists like levamisole and pyrantel bind to the receptor, causing the channel to open and remain in a persistent active state, leading to depolarization block and spastic paralysis (Robertson et al., 2013, PubMed). Conversely, some antagonists or pore-blockers specifically target the open conformation to inhibit ion flow. This receptor is composed of various subunits, such as UNC-38 and UNC-29, which provide the structural basis for its cation selectivity (UniProt). Because these receptors differ significantly from mammalian subtypes, they offer a high degree of therapeutic selectivity for treating helminth infections (Wolstenholme, 2011, PubMed). Understanding the transition to the open channel state is crucial for developing new drugs that can overcome resistance in species like Haemonchus contortus.

Other names
Levamisole-sensitive nicotinic acetylcholine receptorL-type nAChRNematode neuromuscular junction acetylcholine receptorUNC-38/UNC-29/UNC-63 receptor complexNematode muscle nAChR
02

Mechanism of action

Agonist-induced persistent activation leading to spastic paralysis; Open-channel blockade; Competitive antagonism.

03

Biological functions

Neuromuscular transmissionMuscle contractionLocomotionSignal transduction
04

Disease associations

HelminthiasisAscariasisHookworm infectionTrichuriasis
05

Safety considerations

Anthelmintic resistanceHost-parasite selectivity marginsCholinergic side effects in hosts at high concentrations
06

Interacting drugs

Levamisole

6 more in the full profile.

07

Biomarkers

Fecal egg count reduction (FECR)Parasite motility inhibitionElectrophysiological response

Beyond the preview

Go deeper on Nematode muscle nicotinic acetylcholine receptor (nAChR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nematode muscle nicotinic acetylcholine receptor (nAChR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call